within the isoprenoid binding site of RhoGDI: Ac-KKSRRC
(S-geranylgeranyl) (termed CR6-gg). The cross-linking signal
is decreased by roughly 75% in the presence of 5 µM CR6-
gg, and nearly 80% in the presence of 50 µM prenylated
peptide; notable competition was also observed using AFC
as a competitor. These results imply that photoprobe 2 and
CR6-gg are competing for the same isoprenoid binding site,
thus suggesting that 2 is an effective prenylcysteine mimic.
Direct comparison between DATFP-based 2 reported here
and earlier benzophenone-based probes is difficult because
the methods used for detection were different (biotin/
streptavidin versus radioactivity, respectively). However,
using a compound analogous to 2 that retained the biotin
reporter but replaced the DATFP moiety with a benzo-
phenone group made a comparison possible. Irradiation of
2 and its benzophenone-containing counterpart with RhoGDI
at comparable concentrations suggests that 2 may be a
somewhat more efficient cross-linking agent. Moreover, 2
appears to be the more specific reagent since its photolabeling
of RhoGDI can be significantly attenuated by the inclusion
of competitors such as CR6-gg and AFC. In contrast, cross-
linking by the benzophenone homologue of 2 is relatively
unaffected by the addition of these competitors at comparable
concentrations.
Figure 2. Autoradiographic analysis of reaction products detected
by SDS-PAGE, blotting, and treatment with HRP-conjugated
streptavidin following photolabeling of RhoGDI by 2 alone and in
the presence of various potential competitors. Reactions, irradiated
for 2 min, were performed using 4.0 µM RhoGDI. Lane assign-
ments: (1) 500 nM 2; (2) 200 nM 2; (3) 200 nM 2, 5 µM CR6-gg;
(4) 200 nM 2, 50 µM CR6-gg.
To examine the utility of photoprobe 2, we chose RhoGDI
for photolysis experiments because this cytosolic protein is
known to interact with geranylgeranylated Rho proteins, and
has been shown to possess an isoprenoid binding site.37
Irradiating RhoGDI under various conditions established that
2 min of irradiation in our system resulted in no detectable
protein degradation, as judged by SDS-PAGE. RhoGDI (4.0
µM) was then irradiated in the presence of 2 at multiple
concentrations, and the reactions were first subjected to SDS-
PAGE, blotted to nitrocellulose and treated with HRP-
conjugated streptavidin. Cross-linking by 2 was detected in
concentrations ranging from 200 nM to 2.0 µM, and a
histogram representing a portion of the resultant chemi-
luminescent signals associated with the blots, as detected by
autoradiography, is presented in Figure 2. Competition
experiments were performed using a prenylated peptide that
not only mimics the C-terminal residues of Rho proteins but
whose farnesylated counterpart is known to affect residues
In addition to protein prenylation processing enzymes,
there are numerous effector, activator, and inhibitory proteins
that contribute to the regulation of prenylated Ras and Ras-
like proteins, virtually all of which have the potential of
possessing isoprenoid binding sites. Discovering the molec-
ular basis for prenylated protein recognition is a necessary
step in understanding how these proteins, and their possible
oncoprotein isoforms, operate. Small molecules such as 1
and 2, acting as prenylated protein mimics, offer a means to
access these details. Since many putative prenyl-binding
proteins may be membrane bound, photoaffinity labeling
reagents may prove to be superior to other methods such as
X-ray crystallography and NMR for elucidating such struc-
tural information. Greater specificity of photoprobe-protein
interactions may likely occur by using photoactivatable
peptides, and efforts are underway to develop such agents.
The simple compounds presented here, however, appear to
be well-suited for providing initial guidance in studying
proteins that interact with prenylated proteins.
(29) Xue, C.-B.; Becker, J. M.; Naider, F. Tetrahedron Lett. 1992, 33,
1435-1438.
(30) Bernard, M.; Ford, W. T. J. Org. Chem. 1983, 48, 326-332.
(31) Hahn, K. M.; Hastie, S. B.; Sundberg, R. J. Photochem. Photobiol.
1992, 55, 17-27.
(32) Theodore, L. J.; Nelson, W. L.; Dave, B.; Giacomini, J. C. J. Med.
Chem. 1990, 33, 873-877.
(33) Willchek, M., Bayer, E. A., Eds. AVidin-Biotin Technology;
Acknowledgment. The authors thank Dr. George
O’Doherty for invaluable advice during the preparations of
these compounds. This work was supported by a grant from
the National Institutes of Health (GM58442).
Academic Press: San Diego, 1990; Vol. 184.
(34) Biotinylated prenylated peptides have been prepared via solid-phase
synthesis, where biotin-avidin chemistry was utilized in subsequent
enzymatic assays (Dolence, E. K.; Dolence, J. M.; Poulter, C. D.
Bioconjugate Chem. 2001, 12, 35-43. Liu, L.; Jang, G.-F.; Farnsworth,
C.; Yokoyama, K.; Glomset, J. A.; Gelb, M. H. Methods Enzymol. 1995,
250, 189-206).
Supporting Information Available: Product syntheses
and characterization as well as a description of the prepara-
tion of acyl chloride 11, experimental procedures for
photolysis experiments, and details of the comparison
between 2 and its benzophenone-containing homologue. This
material is available free of charge via the Internet at
(35) Yang, C.-C.; Marlowe, C. K.; Kania, R. J. Am. Chem. Soc. 1991,
113, 3177-3178.
(36) It should be noted that instead of biotinylation of the amine-
containing prenylcysteine compound 12 in Scheme 2, attempts were made
to synthesize N-biotinylated cysteine methyl ester and then alkylate its free
thiol with bromide 8. This method did not give reproducible results. The
potential for oxidation of the cysteinyl sulfhydryl group as well as disulfide
formation complicated this reaction. The method shown in Scheme 2 is
considerably more reliable.
(37) Hoffman, G. R.; Nassar, N.; Cerione, R. A. Cell 2000, 100, 345-
356.
OL026752A
612
Org. Lett., Vol. 5, No. 5, 2003